BioLife Solutions Inc (BLFS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, BioLife Solutions Inc (BLFS) has a cash flow conversion efficiency ratio of 0.013x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($4.92 Million) by net assets ($371.89 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
BioLife Solutions Inc - Cash Flow Conversion Efficiency Trend (1989–2025)
This chart illustrates how BioLife Solutions Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of BioLife Solutions Inc for a breakdown of total debt and financial obligations.
BioLife Solutions Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BioLife Solutions Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Allianz Malaysia Bhd
KLSE:1163
|
0.024x |
|
Lingda Group Co Ltd
SHE:300125
|
0.033x |
|
Banco Products (I) Limited
NSE:BANCOINDIA
|
0.009x |
|
Lampsa Hellenic Hotels S.A
AT:LAMPS
|
0.071x |
|
Jiangsu Olive Sensors High-Tech Co Ltd
SHE:300507
|
-0.025x |
|
KPI Green Energy Limited
NSE:KPIGREEN
|
0.007x |
|
Medincell SA
PA:MEDCL
|
0.465x |
|
Zhejiang Dehong Automotive
SHG:603701
|
-0.014x |
Annual Cash Flow Conversion Efficiency for BioLife Solutions Inc (1989–2025)
The table below shows the annual cash flow conversion efficiency of BioLife Solutions Inc from 1989 to 2025. For the full company profile with market capitalisation and key ratios, see BioLife Solutions Inc market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $371.89 Million | $20.11 Million | 0.054x | +123.84% |
| 2024-12-31 | $348.91 Million | $8.43 Million | 0.024x | +165.28% |
| 2023-12-31 | $337.66 Million | $-12.50 Million | -0.037x | -58.79% |
| 2022-12-31 | $364.19 Million | $-8.49 Million | -0.023x | -129.61% |
| 2021-12-31 | $476.37 Million | $-4.84 Million | -0.010x | -131.98% |
| 2020-12-31 | $205.25 Million | $6.51 Million | 0.032x | +117.27% |
| 2019-12-31 | $83.03 Million | $1.21 Million | 0.015x | -73.15% |
| 2018-12-31 | $43.15 Million | $2.35 Million | 0.054x | -9.23% |
| 2017-12-31 | $10.09 Million | $605.00K | 0.060x | +104.39% |
| 2016-12-31 | $3.17 Million | $-4.33 Million | -1.367x | -170.91% |
| 2015-12-31 | $9.86 Million | $-4.97 Million | -0.504x | -122.32% |
| 2014-12-31 | $13.94 Million | $-3.16 Million | -0.227x | -1962.55% |
| 2013-12-31 | $-13.27 Million | $146.01K | -0.011x | +83.93% |
| 2012-12-31 | $-12.49 Million | $854.93K | -0.068x | -177.33% |
| 2011-12-31 | $-11.18 Million | $-989.92K | 0.089x | -32.50% |
| 2010-12-31 | $-9.55 Million | $-1.25 Million | 0.131x | -57.46% |
| 2009-12-31 | $-7.83 Million | $-2.41 Million | 0.308x | -24.55% |
| 2008-12-31 | $-5.17 Million | $-2.11 Million | 0.409x | -62.74% |
| 2007-12-31 | $-2.47 Million | $-2.71 Million | 1.097x | +127.74% |
| 2006-12-31 | $180.09K | $-712.20K | -3.955x | +73.60% |
| 2005-12-31 | $38.48K | $-576.33K | -14.977x | -1882.23% |
| 2004-12-31 | $612.96K | $515.10K | 0.840x | +233.41% |
| 2003-12-31 | $1.36 Million | $-854.23K | -0.630x | -113.04% |
| 2002-12-31 | $-554.25K | $-2.68 Million | 4.831x | +156.81% |
| 2001-12-31 | $310.77K | $-2.64 Million | -8.504x | -964.52% |
| 2000-12-31 | $3.63 Million | $-2.90 Million | -0.799x | -145.54% |
| 1999-12-31 | $818.40K | $-266.26K | -0.325x | -1699.60% |
| 1998-12-31 | $1.43 Million | $29.12K | 0.020x | +103.35% |
| 1997-12-31 | $2.46 Million | $-1.49 Million | -0.608x | -17.07% |
| 1996-12-31 | $3.99 Million | $-2.07 Million | -0.519x | -34.00% |
| 1995-12-31 | $3.98 Million | $-1.54 Million | -0.387x | 0.00% |
| 1994-12-31 | $3.98 Million | $-1.54 Million | -0.387x | +21.05% |
| 1993-12-31 | $5.30 Million | $-2.60 Million | -0.491x | +67.30% |
| 1992-12-31 | $5.60 Million | $-8.40 Million | -1.500x | -318.60% |
| 1991-12-31 | $12.00 Million | $-4.30 Million | -0.358x | +21.17% |
| 1990-12-31 | $5.50 Million | $-2.50 Million | -0.455x | -15.38% |
| 1989-12-31 | $3.30 Million | $-1.30 Million | -0.394x | -- |
About BioLife Solutions Inc
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, inc… Read more